Oncology Programs

Oncology Programs

Request information

Dejar vacío:

Please enter the text that appears in the image below. If you can't read it, try another image by pressing the reload button  

CAPTCHA Image
  • Description

    Lung cancer is the leading cause of cancer death among men and women in most parts of the world. Patients with early stage disease, rarely develop any symptoms and survival benefit obtained through routine screening have not been demonstrated. As a result, lung cancer is often diagnosed in advanced stages, when cure is very difficult to achieve. Despite remarkable advances in the identification of predictors of response and the introduction of new chemotherapy, the impact on patient survival is not clear yet.

    Our health institutions will provide the possibility of the application of novel products developed at the Center of Molecular Immunology, which have shown excellent results in increasing the quality of life of patients with these cancers.

    CimaVax EGF vaccine is the only registered therapeutic vaccine for advanced non-small cell cancer lung cancer (NSCLC), stages III and IV. It ts the most common type of lung cancer. This
    drug has very low toxicity and allow patients to maintain a good quality of life.

    The induction phase lasts for 2 months, corresponding to the application of 16 pairs of vials (4 vials x 4 vaccine applications), Cyclophosphamide and saline solutions. The first dose will be given in our health centers and you can continue the treatment in Cuba or in your country. You choose.

  • Consults

    • Initial evaluation / Medical History
    •  Issuance of Medical Certificates
  • Researchs

    Diagnostic tests:

    •  CBC, ESR, full coagulogram
    •  Alkaline Phosphatase
    •  Blood (Serum) Glutamic-Oxaloacetic Transaminase (SGOT) Test, Blood (Serum)
    • Glutamate Pyruvate Transaminase (SGPT) Test
    •  Urea, creatinine, uric acid
  • Not Include

    • Use of medications not included in this program, blood and blood products.
    • Other Diagnostic tests which might be necessary after patient assessment or derived from test results included in the medical program.
  • Request Service View Terms and Conditions Review
  • Description

    It is a cancer medicine with antitumor effect either in its application as monotherapy or in combination with radiotherapy and chemotherapy, increasing survival time, quality of life. It has excellent tolerance even with prolonged treatment.

    It is approved for the treatment of patients with advanced cancer of head and neck, high-grade malignant glioma (a type of brain tumor) in adults and children and in advanced esophageal cancer.

    CIMAher EGF 24 pairs of vials for 6 weeks treatment.  The induction phase lasts six weeks corresponding to the application of 24 pairs of vials (4 vials x 6 vaccine applications), Cyclophosphamide and saline solutions.  The first dose will be given in our health centers and you can continue the treatment in Cuba or in your country. You choose.

  • Consults

    •  Initial evaluation and preparation of the clinical history.
    •  Pre-application medical checkup .
  • Include

     Cyclophosphamide 200mg

  • Request Service View Terms and Conditions Review

Use of cookies: This website uses its own and third-party cookies for technical purposes for the proper functioning of the website, analytics for traffic measurement and marketing. There may be links to third-party websites with third-party privacy policies that you can decide whether or not to accept when you access them. More information in Política de Cookies

Accept cookies Rechazar cookies Manage cookies